Mobile

Immunogenicity and Safety of the Trivalent Influenza Vaccine (Split-Virion, Inactivated), Northern Hemisphere 2013-2014 Formulation (Intradermal Route)

Mise à jour : Il y a 4 ans
Référence : U1111-1127-7490

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To evaluate the compliance, in terms of immunogenicity, of the ID influenza vaccine NH 2013-2014 formulation with the requirements of the Committee for Medicinal Products for Human Use (CHMP) Note for Guidance (NfG) CPMP/BWP/214/96 in both age groups To describe the safety of the ID influenza vaccine NH 2013-2014 formulation in both age groups

Critère d'inclusion

  • Prophylaxis of influenza (2013-2014 Northern Hemisphere Season)

Liens